Lucidenic acid B

TargetMol
Product Code: TAR-TN1880
Supplier: TargetMol
CodeSizePrice
TAR-TN1880-1mg1mg£259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1880-5mg5mg£542.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1880-1mL1 mL * 10 mM (in DMSO)£575.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TN1880-10mg10mg£744.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Lucidenic acid B shows antioxidative, and anti-invasive effects, it inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Lucidenic acid B also has chemopreventive potential, it induces apoptosis in human leukemia cells via a mitochondria-mediated pathway.
CAS:
95311-95-8
Formula:
C27H38O7
Molecular Weight:
474.594
Pathway:
Chromatin/Epigenetic; DNA Damage/DNA Repair; Apoptosis; Proteases/Proteasome
Purity:
0.98
SMILES:
C[C@H](CCC(O)=O)[C@H]1CC(=O)[C@@]2(C)C3=C(C(=O)[C@@H](O)[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1C[C@@H]3O
Target:
BCL; PARP; Caspase

References

Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway.J Agric Food Chem. 2008 Jun 11;56(11):3973-80.